How Long Does It Take for Oxycodone to Get Out of Your System?

Oxycodone has an elimination half-life of roughly three to four hours in healthy adults, meaning the body clears about half the drug from the bloodstream every few hours after a dose. In practical terms, most of the parent drug is gone from blood within a day of a single dose, though metabolites linger longer and drug tests can detect traces well beyond that window. The real answer depends on what you mean by “out of your system,” because the timeline looks very different depending on whether you are talking about blood levels, a urine screen, or the experience of withdrawal.

How the Body Breaks Down Oxycodone

Oxycodone is processed primarily in the liver through two enzyme pathways. The larger share of the work is done by CYP3A4 (and the related CYP3A5), which converts oxycodone into noroxycodone through a process called N-demethylation. A smaller but clinically relevant pathway runs through CYP2D6, which converts oxycodone into oxymorphone, a metabolite with its own painkilling activity.¹ These metabolites are then broken down further and eventually excreted, mostly through the kidneys. Only about 10% of oxycodone leaves the body unchanged in urine; the rest exits as metabolites.²

This matters for clearance timing because even after the parent drug drops below detectable levels in blood, those metabolites are still circulating and being filtered out. A drug test looking for noroxycodone or noroxymorphone can come back positive long after oxycodone itself is undetectable.

The Basic Timeline in Healthy Adults

Studies in cancer patients given a single oral dose of about 9 mg found a mean elimination half-life of roughly 3.5 hours. When the same patients took 10 mg every four hours on a regular schedule, the drug did not accumulate, and steady-state plasma concentrations hovered around 35 micrograms per liter.³ That means if you stop taking oxycodone after a period of regular use at normal doses, the drug itself should be largely cleared from your blood within about 18 to 20 hours, which is roughly five to six half-lives.

A pilot study tracking blood levels after a single 10 mg immediate-release tablet found that oxycodone and its primary metabolite noroxycodone both peaked at about 1.5 hours. Oxycodone itself was detectable in blood up to 9 hours, while noroxycodone and noroxymorphone were still showing up at the 24-hour mark.⁴ So even a single standard dose leaves a metabolic footprint that outlasts the drug itself by many hours.

Detection Windows by Test Type

Different biological samples hold onto evidence of oxycodone use for different lengths of time, which is why the answer to “how long does it stay in your system” shifts depending on who is asking and what kind of test they are using.

Blood

In a controlled study where 12 healthy volunteers received a single 20 mg controlled-release dose, oxycodone and noroxycodone were frequently detectable in blood starting as early as 30 minutes to 2 hours after the dose, with specimens collected out to 52 hours.⁵ For immediate-release formulations at lower doses, the parent drug tends to drop below detection thresholds faster, around 9 hours, though metabolites persist to at least 24 hours.⁴ Blood testing is most useful in acute clinical or forensic contexts rather than for monitoring long-term use.

Oral Fluid (Saliva)

Oxycodone shows up in saliva quickly, often within 15 to 30 minutes of a dose, and concentrations in saliva can be far higher than in blood plasma. One study of cancer patients found mean salivary oxycodone concentrations of about 336 micrograms per liter compared with about 38 micrograms per liter in plasma.⁶ The high saliva-to-plasma ratio means oral fluid tests can pick up oxycodone readily, though the correlation between saliva and plasma levels was poor in that study, making saliva an unreliable way to estimate exact blood concentrations. Roadside and workplace oral fluid tests generally detect oxycodone for one to four days after last use, depending on dose and testing sensitivity.

Urine

Urine is the most common specimen for drug screening. Because metabolites continue to be filtered through the kidneys well after the parent drug is gone from blood, urine tests typically have a longer detection window than blood. For standard immunoassay urine panels, oxycodone use is generally detectable for two to four days after the last dose at therapeutic levels, though heavier or prolonged use can extend that window. One research model developed for clinical compliance testing was able to predict urine oxycodone concentrations within 10% accuracy for 90% of patients after 10 to 14 days of steady dosing, suggesting that once you stop taking the drug, urinary levels fall off in a fairly predictable pattern.⁷

Hair

Hair testing operates on a completely different timescale. Drugs and their metabolites get incorporated into the hair shaft as it grows, and a standard 1.5-inch hair sample can theoretically reflect drug exposure over the prior 90 days. Hair testing is used for pre-employment screening and forensic investigations far more than for medical purposes. It will not catch very recent use, since it takes about a week for a new hair segment containing the drug to emerge from the scalp.

Immediate-Release vs Controlled-Release Formulations

Formulation matters more than people realize. Immediate-release oxycodone is absorbed quickly and peaks in the blood within about an hour and a half. Controlled-release (CR) tablets are designed with two phases: a fast-absorbing component with a half-life of absorption around 37 minutes, accounting for roughly 38% of the dose, and a slow phase with a half-life of absorption around 6.2 hours, carrying the remaining 62%.⁸ This slow drip of absorption means CR tablets keep feeding drug into the bloodstream for much longer, and the tail end of that absorption process actually slows the apparent elimination of the drug from the body.⁹

In plain terms: if you take a CR tablet, the drug hangs around longer not just because it was released slowly into your gut, but because that slow release actually changes how fast the body clears it. So the answer to “how long until it’s out of my system” after a CR dose is meaningfully longer than after an IR dose of the same total milligrams.

Liver Health Changes Everything

Because oxycodone depends so heavily on liver enzymes for breakdown, liver disease dramatically slows clearance. A study of patients with cirrhosis who later received liver transplants illustrates this starkly. Before transplantation, the median elimination half-life of oxycodone was about 14 hours, with some patients as high as 24 hours. After receiving a healthy liver, the same patients had a median half-life of 3.4 hours.¹⁰ That is a roughly fourfold difference. Clearance improved from 0.26 liters per minute to 1.13 liters per minute after transplant. If you have significant liver disease, oxycodone stays in your body far longer than the standard references suggest, and the risk of accumulation with repeated doses is much higher.¹¹

Kidney Disease and Metabolite Buildup

Even though the liver does the heavy metabolic lifting, the kidneys handle the final excretion of oxycodone and its metabolites. In people with chronic kidney disease, peak plasma concentrations of oxycodone can be about 50% higher than in healthy individuals, and the half-life is prolonged.² The bigger concern with kidney disease is metabolite accumulation. Noroxycodone and noroxymorphone pile up when the kidneys cannot filter them efficiently, which can contribute to side effects even if the parent drug is being metabolized at a normal rate in the liver.¹² For patients on hemodialysis, oxycodone’s low molecular weight and limited volume of distribution mean it can be partially removed during a dialysis session, but it still requires careful dose adjustment.

How Age Affects Clearance

Getting older slows oxycodone clearance in a dose-dependent way that starts to become clinically meaningful past about 60. A population pharmacokinetic study found that the context-sensitive half-time at steady state increased from about 3.8 hours at age 25 to 4.6 hours at age 85, with simulations suggesting a 20% increase in oxycodone concentration in elderly patients compared with younger ones.¹³

A study of postoperative orthopedic patients across multiple age groups put a finer point on this. In patients over 80, total body clearance was about 34% lower than in patients aged 20 to 40, and oxycodone plasma concentrations from 8 hours onward were more than double those in the youngest group.¹⁴ The study found no significant sex-related differences in clearance. It also found a linear correlation between kidney filtration rate and oxycodone clearance, which makes sense given that declining kidney function is one of the mechanisms behind age-related changes. Body weight also plays a role: total body weight was identified as a significant covariate for oxycodone clearance and distribution volume in surgical patients, meaning heavier individuals may distribute the drug differently.¹⁵

Drug Interactions That Slow or Speed Clearance

Because CYP3A4 handles the major metabolic pathway for oxycodone, anything that inhibits or boosts that enzyme has a large effect on how long the drug sticks around. The antifungal ketoconazole, a potent CYP3A4 inhibitor, increased oxycodone blood exposure two- to threefold in a controlled study.¹⁶ On the flip side, CYP3A4 inducers like rifampin (used for tuberculosis) speed up oxycodone metabolism, causing a significant drop in drug exposure and potentially making the drug less effective for pain control.¹⁷

Blocking CYP2D6 alone, for example with the antidepressant paroxetine, had minimal effect on oxycodone levels even though it cut the production of the active metabolite oxymorphone nearly in half. But when both CYP2D6 and CYP3A4 were inhibited simultaneously (paroxetine plus the antifungal itraconazole), oxycodone exposure jumped about 2.9-fold and peak concentration roughly 1.8-fold.¹⁸ The practical takeaway: if you are on a medication that blocks CYP3A4, especially common antifungals, certain antibiotics, or grapefruit juice in large quantities, oxycodone will clear your system more slowly, and the risk of side effects goes up. CYP2D6 inhibitors alone are less of a concern for clearance time, though they do alter the metabolite profile.

Genetic Variation in How Fast You Metabolize Oxycodone

Not everyone’s CYP2D6 enzyme works at the same speed. People are genetically classified along a spectrum from poor metabolizers (PM), who produce very little functional enzyme, to ultra-rapid metabolizers (UM), who produce too much. A study in postoperative patients found that the ratio of oxymorphone to oxycodone in blood was about 0.10 in poor metabolizers and 0.28 in ultra-rapid metabolizers, a nearly threefold difference in how actively that enzyme pathway was running.¹⁹ Poor metabolizers also consumed more oxycodone to achieve the same pain relief, consistent with the idea that they were producing less of the active metabolite oxymorphone.

There is stronger evidence linking both CYP2D6 and CYP3A genetic variations to therapeutic outcomes with oxycodone.²⁰ For clearance time specifically, CYP2D6 status alone does not change how fast oxycodone itself disappears (since CYP3A4 handles the dominant pathway), but it does change the metabolite mix in your blood and urine, which can affect drug test results and side-effect profiles.

When Withdrawal Starts vs When the Drug Is Actually Gone

This is a distinction that trips people up. Physical withdrawal symptoms from oxycodone typically begin 6 to 10 hours after the last dose in someone who has developed physical dependence.²¹ That does not mean the drug is fully out of your system at that point. It means blood levels have dropped enough that the brain’s adapted opioid receptors start signaling distress. The drug and its metabolites may still be detectable in blood and will almost certainly be detectable in urine for days afterward. Withdrawal is about the brain’s tolerance to falling drug levels, not about complete clearance. A person in early withdrawal will still test positive on a drug screen.

False Positives on Oxycodone Screens

Standard immunoassay urine drug screens are not perfectly specific. One documented scenario involves patients taking oral naltrexone, a medication used to treat opioid and alcohol use disorders. Naltrexone’s metabolite, noroxymorphone, has been shown to trigger a false-positive result on oxycodone urine screens. In at least one documented case, confirmatory testing was needed to show that the metabolite of naltrexone, not actual oxycodone use, was the source of the positive result.²² If you are taking naltrexone and get flagged on an oxycodone screen, ask your provider about confirmatory testing before assuming the result is accurate. This is a known pitfall in addiction medicine settings where patients on naltrexone are being monitored for opioid abstinence.

Oxycodone in Breast Milk

For nursing mothers, “out of your system” carries another dimension. Oxycodone concentrates in breast milk at roughly three times the level found in maternal blood plasma, and there is a strong correlation between plasma and milk levels while the mother is actively taking the drug.²³ In the 48 hours after stopping, that correlation weakens and some mothers show persistence of oxycodone in breast milk even as their plasma levels drop, suggesting the drug clears from milk more slowly than from blood in some individuals.

A more recent study of mothers given oxycodone after caesarean delivery confirmed the milk-to-plasma ratio of about 3.2 and estimated that even in the highest-exposure scenario, a breastfed neonate’s estimated weight-adjusted dose would remain under 10% of the maternal dose.²⁴ That 10% threshold is generally considered the safety benchmark for drug exposure through breast milk. Short-term, low-dose oxycodone use appears compatible with breastfeeding for most mothers, but the fact that the drug lingers in milk longer than in blood means timing feedings around doses is not as straightforward as the plasma half-life alone would suggest.